Molecular Partners Balance Sheet Health
Financial Health criteria checks 6/6
Molecular Partners has a total shareholder equity of CHF176.4M and total debt of CHF0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CHF198.4M and CHF21.9M respectively.
Key information
0%
Debt to equity ratio
CHF0
Debt
Interest coverage ratio | n/a |
Cash | CHF186.89m |
Equity | CHF176.43m |
Total liabilities | CHF21.92m |
Total assets | CHF198.35m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0QXX's short term assets (CHF192.5M) exceed its short term liabilities (CHF14.4M).
Long Term Liabilities: 0QXX's short term assets (CHF192.5M) exceed its long term liabilities (CHF7.5M).
Debt to Equity History and Analysis
Debt Level: 0QXX is debt free.
Reducing Debt: 0QXX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0QXX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 0QXX has sufficient cash runway for 2.6 years if free cash flow continues to grow at historical rates of 11.2% each year.